The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index; none of the 51 sources its claims cite is checked for support yet.
Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition
Open accessAbstract
Phospholamban (PLN) is a 52 amino acid regulin that allosterically modulates the activity of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) in the heart muscle. In its unphosphorylated form, PLN binds SERCA within its transmembrane (TM) domains, approximately 20 Å away from the Ca2+ binding site, reducing SERCA’s apparent Ca2+ affinity (pKCa) and decreasing cardiac contractility. During the enzymatic cycle, the inhibitory TM domain of PLN remains anchored to SERCA, whereas its cytoplasmic region transiently binds the ATPase’s headpiece. Phosphorylation of PLN at Ser16 by protein kinase A increases the affinity of its cytoplasmic domain to SERCA, weakening the TM interactions with the ATPase, reversing its inhibitory function, and augmenting muscle contractility. How the structural changes caused by pathological mutations in the PLN cytoplasmic region are transmitted to its inhibitory TM domain is still unclear. Using solid-state NMR spectroscopy and activity assays, we analyzed structural and functional effects of a series of mutations and their phosphorylated forms located in the PLN cytoplasmic region and linked to dilated cardiomyopathy. We found that these missense mutations affect the overall topology and dynamics of PLN and ultimately modulate its inhibitory potency. Also, the changes in the TM tilt angle and cytoplasmic dynamics of PLN caused by these mutations correlate well with the extent of SERCA inhibition. Our study unveils new molecular determinants for designing variants of PLN that outcompete endogenous PLN to regulate SERCA in a tunable manner.
Overview
CoChat Summary
TL;DR
Using solid-state NMR and activity assays, the authors show that dilated cardiomyopathy-linked mutations in the phospholamban cytoplasmic domain alter PLN topology and dynamics, and that these changes correlate with the extent of SERCA inhibition. TM tilt angle and cytoplasmic dynamics emerge as structural determinants of PLN inhibitory potency.
Key findings
- DCM mutations in PLN domain Ia (R9C, R9H, R9L, R25C) change PLN topology and dynamics. For wild-type PLN, the inhibitory orientation has θ = 37.2 ± 0.8° and ρL31 = 198 ± 4°; S16 phosphorylation shifts it to a non-inhibitory state with θ = 35 ± 1° and ρL31 = 200 ± 3°, while RlpCP/CP increases from 20 ± 2% to 49 ± 2%.
- PLNR9H, PLNR25C, PLNR9C, and PLNR9L show altered tilt/rotation and dynamics: PLNR9H shifts from θ = 37 ± 1° to 35.4 ± 0.9° upon phosphorylation; PLNR25C shifts from θ = 39 ± 1° to 36 ± 1°; PLNR9C has θ = 38 ± 1°; PLNR9L has θ = 39 ± 1°. RlpCP/CP values were 179 ± 24% → 186 ± 19% for R9H, 9 ± 1% → 32 ± 4% for R25C, 24 ± 2% for R9C, and 7 ± 1% for R9L.
- In activity assays, pPLNR9H, pPLNR9L, and pPLNR25C had roughly identical ATPase activities and ΔpKCa values; the exception was pPLNR9C, whose S16 phosphorylation did not completely reverse SERCA inhibition.
- ΔpKCa correlated with RlpCP/CP with R² = 0.54 (two-tailed p = 0.051) except for PLNR9H and pPLNR9H outliers, and correlated better with TM tilt angle with R² = 0.62 (two-tailed p = 0.012), indicating larger tilt angles are more inhibitory.
Methods
- Oriented-sample solid-state NMR used a cysteine-null monomeric PLN background (C36A, C41F, C46A) with R9C, R9H, R9L, R25C, or R14del substitutions; proteins were expressed in E. coli, purified, phosphorylated with PKA, and verified by MALDI-MS. Samples were reconstituted in magnetically oriented DMPC:POPC/DHPC bicelles (q = 4.0, 5 mM Yb³⁺, pH 4.2, 27 °C) and analyzed on a 700 MHz Varian VNMRS using SE-SAMPI4, 1D CP, and low-power CP experiments; PISA-SPARKY fits yielded tilt, azimuthal, and order parameters, and RlpCP/CP ratios.
- SERCA activity assays used SERCA1a purified from rabbit skeletal muscle, co-reconstituted with PLN or mutants at a 5:1 molar ratio in DOPC:DOPE (4:1; 2500:1 lipid:SERCA). Enzyme-coupled NADH assays were run at pCa 8.0–5.0, and Hill fits extracted Vmax, Vmin, and pKCa; assays were done in triplicate.
Limitations
- The paper states that it used the AFA monomeric PLN species to avoid monomer–pentamer equilibrium complications, but notes that AFA is a slight gain-of-function mutant with limitations as a functional model; future work will analyze monomer–pentamer equilibrium.
- The paper states that PLNR9C bicelle preparations were unstable, and phosphorylation of PLNR9C and PLNR9L increased aggregation, preventing well-aligned bicelles for NMR analysis.
- Evident from the text: the correlations are moderate (R² = 0.54 and 0.62) and R9H/pR9H are outliers; functional assays used skeletal-muscle SERCA1a rather than cardiac SERCA2a, and R14del appears in Methods but no results are reported for it.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 32 Not checked · 51 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specifically, we found that SERCA’s apparent Ca2+ affinity of these missense variants correlates well with both the extent of the conformational dynamics of their cytoplasmic domains and their TM tilt angles.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Introduction
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that these missense mutations affect the overall topology and dynamics of PLN and ultimately modulate its inhibitory potency.”
- Also stated in: § Introduction · plain
“We found that these mutations affect both the conformational dynamics and the TM orientation (i.e., rotation and tilt angles) of PLN, modulating the extent of SERCA inhibition.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Specifically, we found that SERCA’s apparent Ca2+ affinity of these missense variants correlates well with both the extent of the conformational dynamics of their cytoplasmic domains and their TM tilt angles.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Introduction
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Also, the changes in the TM tilt angle and cytoplasmic dynamics of PLN caused by these mutations correlate well with the extent of SERCA inhibition.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that these missense mutations affect the overall topology and dynamics of PLN and ultimately modulate its inhibitory potency.”
- Also stated in: § Introduction · plain
“We found that these mutations affect both the conformational dynamics and the TM orientation (i.e., rotation and tilt angles) of PLN, modulating the extent of SERCA inhibition.”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
42 more claims
Create a free account to see all 83 claims and to verify the 51 references still open.
- It may state two separate claims as one. 26
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Materials and Methods > Bicelle preparation for oriented-sample solid state NMR studies
“sample buffer (20 mM HEPES, 100 mM KCl, 1 mM NaN3, pH 6.5)”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Materials and Methods > Bicelle preparation for oriented-sample solid state NMR studies
“20 mM HEPES, 100 mM NaCl, 1 mM NaN3, and 1 mM TCEP”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Materials and Methods > Cloning, expression, purification, and phosphorylation of PLN variants
“The active cysteine-null monomeric mutant of PLN (C36A, C41F, C46A)”
§ Pathological Mutations in the Phospholamban Cytoplasmic Region Affect its Topology and Dynamics Modulating the Extent of SERCA Inhibition > Results > DCM mutations affect the dynamics and topology of PLN in membrane bilayers.
“the three TM cysteines (Cys36, Cys 41, and Cys42) were mutated into Ala, Phe, and Ala, respectively”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Cardiac excitation–contraction coupling
Bers, D. M. (2002) · Nature · doi:10.1038/415198a · Cited by 4,744
Proton-enhanced NMR of dilute spins in solids
Pines, A., Gibby, M. G., & Waugh, J. S. (1973) · The Journal of Chemical Physics · doi:10.1063/1.1680061 · Cited by 2,493
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Lee, W., Tonelli, M., & Markley, J. L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu830 · Cited by 2,045
A micropeptide encoded by a putative long noncoding RNA regulates muscle performance
Anderson, D. M., Anderson, K. M., Chang, C.-L., Makarewich, C. A., Nelson, B. R., McAnally, J. R., Kasaragod, P., Shelton, J. M., Liou, J., Bassel-Duby, R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.009 · Cited by 1,216
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle
Nelson, B. R., Makarewich, C. A., Anderson, D. M., Winders, B. R., Troupes, C. D., Wu, F., Reese, A. L., McAnally, J. R., Chen, X., Kavalali, E. T., et al. (2016) · Science · doi:10.1126/science.aad4076 · Cited by 788
Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function
SIMMERMAN, H. K. B., & JONES, L. R. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.921 · Cited by 574
Greenberg, B., Butler, J., Felker, G. M., Ponikowski, P., Voors, A. A., Desai, A. S., Barnard, D., Bouchard, A., Jaski, B., Lyon, A. R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00082-9 · Cited by 525
Reconstitution of Membrane Proteins into Lipid-Rich Bilayered Mixed Micelles for NMR Studies
Sanders, C. R., & Landis, G. C. (1995) · Biochemistry · doi:10.1021/bi00012a022 · Cited by 387
Research works printed but not linked: 1
- Weber, 2021, Structural basis for allosteric control of the SERCA-phospholamban membrane complex by Ca2+ and cAMP-dependent phosphorylation, Elife, 10, 10.7554/elife.66226 · doi:10.7554/elife.66226
Cited by
Solid-State NMR Approaches to Study Protein Structure and Protein–Lipid Interactions
Aisenbrey, C., Salnikov, E. S., Raya, J., Michalek, M., & Bechinger, B. (2012) · Methods in molecular biology · doi:10.1007/978-1-0716-5054-7_24 · Cited by 37
Viskupičová, J., & Espinoza-Fonseca, M. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169200 · Cited by 22
Cullen, M., Biancaniello, C., Taškova, K., Miletić, V., Mercadante, D., & Simone, A. D. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c22987 · Cited by 6
Genetic landscape of phospholamban cardiomyopathies
Vafiadaki, E., Chaudhari, I., Soliman, K. M., Eliopoulos, A. G., Kranias, E. G., & Sanoudou, D. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1626242 · Cited by 5
Šeflová, J., Fang, X., Kekenes-Huskey, P. M., Espinoza‐Fonseca, L. M., Bossuyt, J., & Robia, S. L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05123-w · Cited by 3
Self-citation
Metadata
- Authors
- Weber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G.
- Affiliations
- University of Minnesota (US)
- Loyola University Chicago (US)
- Corresponding author
- Veglia, Gianluigi
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 1866
- Issue
- 7
- Pages
- 184370
- ISSN
- 0005-2736 (ISSN-L)
- PMC
- PMC11457527
- OpenAlex
- W4400478201
- Semantic Scholar
- 7c4e2a41ad954ea5628d9757ddf92fbc258e4286
- Cited by
- 8
- References
- 98
- Citations by year
- 2026: 3 · 2025: 4
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- National Institutes of Health (HL144130)
- AHA (19POST34420009)
- NHLBI (HL143816, HL092321)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- phospholamban, SERCA, dilated cardiomyopathy, missense mutations, cytoplasmic domain, transmembrane domain, protein topology, protein dynamics, allosteric regulation, protein phosphorylation, Ser16 phosphorylation, protein kinase A, calcium affinity, cardiac contractility
- MeSH terms
- Phospholamban, Animals, Binding Sites, Calcium, Calcium-Binding Proteins, Cytoplasm, Humans, Mutation, Phosphorylation, Protein Binding, Sarcoplasmic Reticulum Calcium-Transporting ATPases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition. https://app.cochat.ai/papers/10.1016/j.bbamem.2024.184370
- The paper
- Weber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G. (2024). Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition. Biochimica et Biophysica Acta (BBA) - Biomembranes. https://doi.org/10.1016/j.bbamem.2024.184370
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.